# Lung cancer in East Africa and the relationship to HIV-1 infection: epidemiology, molecular characterization and imaging

> **NIH NIH U54** · CASE WESTERN RESERVE UNIVERSITY · 2021 · $990,912

## Abstract

The molecular epidemiology of lung cancer in Africa is almost completely unknown, yet molecular profiling and
institution of targeted therapy is now standardly used to influence care in patients with actionable mutations. HIV-
infection is associated with a markedly increased risk of lung cancer, but its association with lung cancer and
how it influences disease outcomes is not well studied. The capacity to correctly diagnose lung cancer on
radiological images, tissue specimen acquisition, and subsequent histologic confirmation compounds the
problem of under and misdiagnosis of lung cancer in Africa, especially with the prevalence and often presumptive
clinical diagnosis of tuberculosis infection. In this consortium proposal, we therefore seek to address the above
stated problems by 1) establishing national lung cancer diagnostic referral networks in Uganda and Tanzania,
which will allow for improved detection of lung cancer and, hence decrease the lung cancer burden; 2)
investigating the role of HIV-1 infection on the incidence and outcomes of lung cancer in the region; 3)
determining the molecular profile of lung cancer in East African countries in order to facilitate advocacy for scale-
up of targeted therapies (including immune-based therapies); 4) building capacity for lung cancer diagnosis and
care in terms of improving imaging, pathology, radiology and tissue acquisition and clinical care of lung cancer
5) creating a lung cancer research collaboration that will build capacity through mentoring of junior researchers
for future leadership in the field. At the end of this project, we envision an African-led lung cancer research
network, clinical expertise for sample acquisition and care, improved pathology and radiology diagnostics
services, a lung cancer screening program, and a large biorepository that should support lung cancer research
in the region for many years to come.

## Key facts

- **NIH application ID:** 10267194
- **Project number:** 5U54CA254566-02
- **Recipient organization:** CASE WESTERN RESERVE UNIVERSITY
- **Principal Investigator:** STANTON L. GERSON
- **Activity code:** U54 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $990,912
- **Award type:** 5
- **Project period:** 2020-09-21 → 2025-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10267194

## Citation

> US National Institutes of Health, RePORTER application 10267194, Lung cancer in East Africa and the relationship to HIV-1 infection: epidemiology, molecular characterization and imaging (5U54CA254566-02). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10267194. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*